Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
James E. Robinson(Tulane University), Robert F. Garry(Tulane University)
Cited by 183
Related Papers
The origins of SARS-CoV-2: A critical review
|Cell|2021|511
Lassa Fever in Post-Conflict Sierra Leone
|PLoS neglected tropical diseases|2014|236
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
|New England Journal of Medicine|2018|197
Discovery of Novel Rhabdoviruses in the Blood of Healthy Individuals from West Africa
|PLoS neglected tropical diseases|2015|75
Ebola Virus Epidemiology and Evolution in Nigeria
|The Journal of Infectious Diseases|2016|37